Table 3.
SAVR: Risk Model for Mortality and Mortality/Morbidity
Variable | Mortality RR | Mortality/morbidity RR |
---|---|---|
Age category | 1.26*** | 1.24*** |
Preoperative dialysis | 3.44*** | 1.86*** |
CLD ≥Moderate | 1.83** | 1.83*** |
Non-cardiac vascular disease | 2.15 (PAD)*** | 1.49*** |
Congestive heart failure | 1.37* | 1.42*** |
Atrial fibrillation | 2.08*** | 1.69*** |
NYHA class | 1.52 (class ≥3)*** | 1.27 (class 3)** |
2.10 (class 4)*** | ||
History of stroke/TIA | 1.38* | 1.32** |
Concomitant CABG | 1.38** | 1.8* |
Shock | 3.97*** | – |
Concomitant mitral regurgitation ≥2 | 1.52** | – |
LV function | – | 1.67 (bad)** |
1.18 (medium)* | ||
DM | – | 1.15* |
1.40 (insulin use)** | ||
History of psychoneurotic disorder | – | 3.57** |
Renal dysfunction (Cr ≥2 mg/dL) | – | 1.43** |
Concomitant mitral stenosis | – | 1.45** |
BMI ≥30 | – | 1.40* |
Coronary lesion | – | 1.24 (≥2VD)* |
1.30 (LMT)* | ||
Female gender | – | 1.14* |
C statistics | 0.732*** | 0.694*** |
*P<0.05; **P<0.01; ***P<0.001. 2VD, 2-vessel disease; RR, relative risk. Other abbreviations as in Table 1.